Carl Zeiss reports €262.6 million in revenue in first quarter
Carl Zeiss Meditec reported €262.6 million in revenue in the first quarter of the fiscal year compared with €241.1 million reported in the same quarter of the previous fiscal year, according to a press release.
Revenue in the Surgical Ophthalmology strategic business unit was reported at €92.6 million in the first quarter, a 13.6% increase from €81.6 million in the same quarter of the previous year.
Revenue in the Ophthalmic Systems strategic business unit was reported at 98.6 million in the first quarter, a 7.5% increase from €91.7 million in the same quarter of the previous year.
Revenue in the Microsurgery strategic business unit was reported at €71.3 million in the first quarter, a 5.2% increase from €67.8 million in the same quarter of the previous year.
Revenue increased 4.2% to €90.2 million in the Europe, Middle East and Africa region, 10.1% to €88.8 million in the Americas region and 13.1% to €83.6 million in the Asia-Pacific region.